Monrat Chulanetra

5PUBLICATIONS
6CO-AUTHORS
Tumour immunologyGlycoconjugatesBiomaterialsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 23, 2023
Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer.

Kodchakorn Mahasongkram, Kantaphon Glab-Ampai, Kanasap Kaewchim

|Oct 28, 2023
Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252.

Kanasap Kaewchim, Kittirat Glab-Ampai, Kodchakorn Mahasongkram

|Jun 28, 2023
Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies.

Kanasap Kaewchim, Kittirat Glab-Ampai, Kodchakorn Mahasongkram

|Jun 24, 2022
Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants.

Kittirat Glab-Ampai, Kanasap Kaewchim, Thanatsaran Saenlom

|Nov 13, 2021
Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase.

Kanasap Kaewchim, Kittirat Glab-Ampai, Kodchakorn Mahasongkram

Pageof 1

Frequent Collaborators

5 joint publications

Kanasap Kaewchim

5 joint publications

Kittirat Glab-Ampai

5 joint publications

Wanpen Chaicumpa

3 joint publications

Thanatsaran Saenlom